scholarly journals The relationship between eating patterns, body image and emotional dysregulation: similarities between an excessive and normal body weight sample

2021 ◽  
Vol 55 (5) ◽  
pp. 1065-1078
Author(s):  
Anna Brytek-Matera ◽  
Kamila Czepczor-Bernat ◽  
Adriana Modrzejewska
Keyword(s):  
Body Image ◽  
Body Weight ◽  
Emotional Dysregulation ◽  
Eating Patterns ◽  
Normal Body ◽  
Normal Body Weight ◽  
The Relationship

scholarly journals Metabolic Obesity in People with Normal Body Weight (MONW)—Review of Diagnostic Criteria

2022 ◽  
Vol 19 (2) ◽  
pp. 624
Author(s):  
Waldemar Pluta ◽  
Wioleta Dudzińska ◽  
Anna Lubkowska
Keyword(s):  
Body Weight ◽  
Diagnostic Criteria ◽  
Normal Body ◽  
Risk Of Mortality ◽  
Diagnostic Models ◽  
Normal Body Weight ◽  
Definition Of ◽  
The Relationship ◽  
Apparently Healthy

Disorders of metabolic obesity with normal body weight (MONW) are widely recognized risk factors for the development of cardiovascular diseases and type 2 diabetes. Despite this, MONW is not diagnosed in clinical practice. There is no consensus on the definition of MONW, and measuring the degree of insulin resistance or obesity among apparently healthy, non-obese patients is not widely applicable. The awareness of the relationship between metabolic disorders such as MONW and a higher risk of mortality from cardiovascular causes and other related diseases prompts the need for action to be taken aimed at creating appropriate diagnostic models that will allow for the effective detection of those with metabolic abnormalities among people with normal body weight. Such actions are decisive in the prevention and treatment of diseases. Therefore, the purpose of this article is to review the MONW diagnostic criteria used over the years.

Neuropeptide Y as a potential biomarker in patients with asthma and obesity

2021 ◽  
Vol 31 (6) ◽  
pp. 759-767
Author(s):  
Yanina S. Shkatova ◽  
Sergey N. Avdeev ◽  
Andrey V. Budnevsky ◽  
Ludmila V. Tribuntceva
Keyword(s):  
Body Weight ◽  
Oxidative Damage ◽  
Neuropeptide Y ◽  
Asthma Control ◽  
Clinical Course ◽  
Inverse Correlation ◽  
Positive Correlation ◽  
Normal Body ◽  
Normal Body Weight ◽  
The Relationship

The phenotype of asthma with obesity is particularly difficult to treat, while its prevalence is increasing. In recent years, special attention has been paid to neuropeptide Y (NPY) due to its possible effect on the severity of the clinical course of asthma.Aim. To identify the relationship between the level of NPY and the clinical course of asthma in patients with obesity and overweight.Methods. The study included 113 patients (27, or 23.89% of men and 86, or 76.11% of women) diagnosed with asthma of moderate severity, whose average age was 57.81 ± 13.05 years. Patients were divided into three groups — with normal body weight, overweight, and obesity. The examination included spirometry, body mass index (BMI), and a questionnaire. Also, Asthma Control Test (ACT) was used. The levels of leptin, adiponectin, NPY, and general oxidative damage were measured in all patients.Results. Asthma control was significantly lower in the group of patients with asthma and obesity compared with the normal body weight and overweight patients. Leptin level was significantly higher in the group of patients with asthma and obesity compared with the normal body weight and overweight patients. The level of NPY was significantly higher in the group of patients with obesity than in the patients with normal body weight and overweight. No significant differences in the level of adiponectin were found between the groups. The NPY level had a high inverse correlation with VLC index, a moderate/medium inverse correlation with forced expiratory volume in 1 sec, forced expiratory flow (FEF) at 25%; forced vital capacity, Tiffno index, FEF 50%, peak expiratory flow, ACT score, and a moderate positive correlation with the level of total oxidative damage.Conclusion. A higher level of NPY is observed in patients with asthma and obesity. This level has an inverse correlation with spirometric parameters, asthma control (evaluated via ACT) and a positive correlation with the level of general oxidative damage, which indicates a possible proinflammatory effect of NPY that contributes to an unfavorable course of asthma. Thus, further studies are required to establish the nature of the relationship between NPY and asthma exacerbations, as well as the mechanism of NPY influence on asthma pathogenesis.

The Relationship Between Adiposity and Risk factors for Cadiovascular Disease at Normal Body Weight Male

2003 ◽  
Vol 20 (1) ◽  
pp. 62
Author(s):  
Woo Sung Kwon ◽  
Jun Su Kim ◽  
Jin Wook Chae ◽  
Keun Mi Lee ◽  
Seung Pil Jung ◽  
...  
Keyword(s):  
Risk Factors ◽  
Body Weight ◽  
Normal Body ◽  
Normal Body Weight ◽  
The Relationship

Monocyte-associated chemokine expression in cells from subcutaneous adipose tissue isolated from operation material in patients during abdominoplasty

2017 ◽  
pp. 70-78
Author(s):  
А.Е. Копасов ◽  
С.Н. Блохин ◽  
С.Г. Морозов
Keyword(s):  
Body Weight ◽  
Adipose Tissue ◽  
Subcutaneous Adipose Tissue ◽  
Aesthetic Surgery ◽  
Normal Body ◽  
Chemokine Expression ◽  
Normal Body Weight ◽  
Functional Features ◽  
Subcutaneous Adipose ◽  
The Relationship

Цель работы - изучение взаимосвязи между уровнем хемокинов и интенсивностью воспалительного процесса в подкожно-жировой ткани (ПЖТ) у лиц с ожирением и нормальной массой тела. Задача работы - определение уровня экспрессии хемокинов, сопряженных с моноцитами/макрофагами, и их рецепторов в клетках ПЖТ, выделенных при проведении абдоминопластики. Пациенты. В период с 2013 по 2017 гг. в Клинике пластической и эстетической хирургии проведены операции абдоминопластики у 262 женщин, биологический материал которых использован в работе. Методы. Состав тела и процент жировой массы определяли методом биоимпедансного анализа. Из образцов ПЖТ из операционного материала выделяли клетки, окрашивали их меченными флуоресцеинами антителами к хемокинам и анализировали на проточном цитометре FACSCalibur по программе SimulSet. Статистический анализ проводили по программе ANOVA. Результаты. Показано, что наличие ожирения оказывает влияние на клеточный состав ПЖТ. Экспрессия хемокинов семейства CC, а также рецепторов хемокинов CCR1, CCR2 и CCR5 в ПЖТ у пациентов с ожирением достоверно выше, чем у пациентов с нормальной массой тела. Заключение. Различия в экспрессии хемокинов на клетках ПЖТ у пациентов с ожирением или с нормальной массой тела отражают функциональные особенности ПЖТ и могут оказывать влияние на развитие осложнений после проведения операции абдоминопластики. AIM: we study the relationship between chemokines and intensity of the inflammatory process in the subcutaneous adipose tissue (SAT) in individuals with obesity and normal body weight. Objective: we determined the expression levels of chemokines associated with monocyte/macrophages, as well as their receptors on the cells of SAT, that were obtained during abdominoplasty. Patients. In this work we have used the biological material of 262 women to whom has been performed an abdominoplasty in the Clinic of plastic and aesthetic surgery from 2013 to 2017 years. Methods. Body composition and the weight of body fat were determined by bioimpedance analysis. SATs have been obtained during abdominoplasty surgery. SAT cells were isolated followed by the staining with fluoresceine labeled antibodies which fluorescence was analyzed using a flow cytometer FACSCalibur according to the program SimulSet. Statistical analysis was carried out using ANOVA. Results. It has been shown that the progressing obesity may affect the SAT cellular composition. The expression of chemokines from CC family and its receptors (CCR1, CCR2 and CCR5) on cells from SAT were significantly higher in patients with obesity compared to the normal body weight patients. Conclusions. Differences in the chemokine expression on SAT cells between patients with obesity and with normal body weight may reflect the functional features of SAT itself and can modify the complication developments after abdominoplasty.

scholarly journals Dieting and Disinhibited Eating Patterns in Adult Women with Normal Body Weight: Does Rumination Matter?

Nutrients ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 2475
Author(s):  
Justyna Waliłko ◽  
Paulina Bronowicka ◽  
Jinbo He ◽  
Anna Brytek-Matera
Keyword(s):  
Body Weight ◽  
Emotional Eating ◽  
Eating Behaviors ◽  
Adult Women ◽  
Eating Patterns ◽  
Repetitive Negative Thinking ◽  
Normal Body ◽  
Negative Thinking ◽  
Disinhibited Eating ◽  
Normal Body Weight

Dieting and disinhibited eating patterns are presented in both clinical and nonclinical samples. Repetitive negative thinking (i.e., rumination) may lead to maladaptive eating behaviors. While numerous studies have focused on dieting and disinhibited eating behaviors in clinical samples, less is known about these behaviors in nonclinical samples with normal body weight. Therefore, the present study aimed to explore how dieting, uncontrolled eating and emotional eating are related to rumination in adult women with normal body weight. One hundred eighty-eight women (Mage = 29.46 ± 8.94; MBMI = 23.16 ± 4.04) were involved in the current study. The Eating Attitudes Test, the Three-Factor Eating Questionnaire-R18 and the Perseverative Thinking Questionnaire were administered to the participants. The results showed that repetitive negative thinking was a partial mediator in the relationship between dieting and uncontrolled eating, as well as in the relationship between dieting and emotional eating. Targeting repetitive negative thinking may be important for reducing disinhibited eating patterns in women with normal body weight.

scholarly journals Body dissatisfaction and body image of female athletes with normal body weight

2016 ◽  
Vol 13 ◽  
pp. e63
Author(s):  
Eirini Koidou ◽  
Souzana Papadopoulou ◽  
Fani Thoma ◽  
Christina Euaggelinou
Keyword(s):  
Body Image ◽  
Body Weight ◽  
Body Dissatisfaction ◽  
Female Athletes ◽  
Normal Body ◽  
Normal Body Weight

scholarly journals POS0358 EVALUATION OF THE EFFECT OF mTOR EXPRESSION ON THE CLINICAL MANIFESTATIONS OF KNEE OSTEOARTHRITIS IN OBESE AND NORMAL WEIGHT PATIENTS

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 409.2-409
Author(s):  
E. Strebkova ◽  
E. Tchetina ◽  
L. Alekseeva
Keyword(s):  
Body Weight ◽  
Knee Pain ◽  
Mammalian Target Of Rapamycin ◽  
Clinical Manifestations ◽  
Normal Weight ◽  
Womac Pain ◽  
Obese Patients ◽  
Normal Body ◽  
Knee Oa ◽  
Normal Body Weight

Background:Currently, a large number of molecular biological and genetic markers are known to be involved in the development of osteoarthritis (OA). The mammalian target of rapamycin (mTOR) signaling pathway is responsible for chondrocyte proliferation, cartilage matrix production, and cell growth. OA is characterized by increased mTOR synthesis, which is accompanied by an increase in proliferative activity and destruction of chondrocytes. Obesity is an important factor in the progression of knee OA. The study of mTOR expression in patients with OA and obesity is an urgent task in the development of personalized OA therapy.Objectives:To determine the expression of mTOR in patients with knee OA in combination with obesity and normal body weight. To evaluate the effect of mTOR on the clinical manifestations of OA in patients with different body mass index (BMI).Methods:The study included 73 female patients aged 45-65 y.o. with Kellgren-Lawrence stage II-III knee OA. The patients were divided into 2 groups: group 1 (n=50) with obesity (BMI > 30 kg / cm2) and group 2 (n=23) with normal or increased body weight (BMI < 30 kg/cm2). The average age of patients with obesity is 56.5 ± 5.87 years, without obesity - 58.7 ± 5.43 years. Clinical manifestations were evaluated by a WOMAС. RNA was isolated from the patients ‘ blood samples, which was used to determine the expression of mTOR.Results:Patients with knee OA with and without obesity did not differ in age. OA develops at an earlier age in obese patients, than in non-obese patients (p < 0.001). Patients from 1 group had a high BMI > 30 kg/m2 at the onset of OA. Obese patients had more severe knee OA is significantly more often detected: Kellgren-Lawrence stage III was determined in 10% of obese patients and in 4.35% - without obesity (p < 0.001). Significantly higher values of the WOMAC index pain, stiffness, joint functional failure, and total WOMAC were observed in obese patients (p = 0.006, p = 0.039, p = 0.037, and p = 0.014, respectively). Obese patients had higher VAS pain scores (p < 0.05) compared to patients with a lower BMI. Obese patients had a higher mTOR expression (p < 0.05) of 8.02±8.62, compared to non-obese patients. High mTOR expression was associated with VAS knee pain (r=0.78; p < 0.05) and WOMAC pain (r=0.89; p<0.05) in obese patients (Table 1).Table 1.Correlation of m-TORParametersmTOR (1 group, n=50)mTOR (2 group, n=23)Body weightр > 0,05р > 0,05Pain (VAS)r=0,78; р<0,05p = 0,07; r = 0,45Pain (WOMAC)r=0,89; р<0,05р > 0,05Total WOMACр > 0,05р > 0,05Conclusion:Our study showed that patients with obesity and knee OA have higher rates of mTOR expression, compared to patients with normal body weight. High mTOR expression correlates with the severity of knee pain in obese patients. Thus, the evaluation of mTOR expression in obese patients and knee OA plays an important role in predicting the severity of clinical manifestations of OA, and may influence the choice of personalized therapy tactics for such patients.Disclosure of Interests:None declared

Sign in / Sign up

Export Citation Format

Share Document